Related references
Note: Only part of the references are listed.Relationship of glycaemic control and hypoglycaemic episodes to 4-year cardiovascular outcomes in people with type 2 diabetes starting insulin
N. Freemantle et al.
DIABETES OBESITY & METABOLISM (2016)
HbA1c below 7 % as the goal of glucose control fails to maximize the cardiovascular benefits: a meta-analysis
Pin Wang et al.
CARDIOVASCULAR DIABETOLOGY (2015)
Is HbA1c a valid surrogate for macrovascular and microvascular complications in type 2 diabetes?
T. Bejan-Angoulvant et al.
DIABETES & METABOLISM (2015)
The Relation Between HbA1c and Cardiovascular Events in Patients With Type 2 Diabetes With and Without Vascular Disease
Guido Kranenburg et al.
DIABETES CARE (2015)
Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes
Rodney A. Hayward et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Prognostic importance of baseline and serial glycated hemoglobin levels in high-risk patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study
Claudia R. L. Cardoso et al.
ACTA DIABETOLOGICA (2015)
Executive Summary: Heart Disease and Stroke Statistics-2014 Update A Report From the American Heart Association
Alan S. Go et al.
CIRCULATION (2014)
Global estimates of diabetes prevalence for 2013 and projections for 2035
L. Guariguata et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
Frailty, Sarcopenia and Diabetes
John E. Morley et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2014)
Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes
S. Zoungas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trials
Francesco Giorgino et al.
YEAR IN DIABETES AND OBESITY (2013)
A study on serum advanced glycation end products and its association with oxidative stress and paraoxonase activity in type 2 diabetic patients with vascular complications
Savita Bansal et al.
CLINICAL BIOCHEMISTRY (2013)
Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: the SMART risk score
Johannes A. N. Dorresteijn et al.
HEART (2013)
Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds
S. Zoungas et al.
DIABETOLOGIA (2012)
Glycosylated Hemoglobin in Relationship to Cardiovascular Outcomes and Death in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
Yurong Zhang et al.
PLOS ONE (2012)
Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
William C. Cushman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Intensive Glucose-Lowering Therapy Reduces Cardiovascular Disease Events in Veterans Affairs Diabetes Trial Participants With Lower Calcified Coronary Atherosclerosis
Peter D. Reaven et al.
DIABETES (2009)
Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes New results from the ADVANCE trial
Sophia Zoungas et al.
DIABETES CARE (2009)
Is Hyperglycemia Associated with Frailty Status in Older Women?
Caroline S. Blaum et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2009)
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
William Duckworth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxides
M. Mastorikou et al.
DIABETIC MEDICINE (2008)
Effects of intensive glucose lowering in type 2 diabetes
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
10-year follow-up of intensive glucose control in type 2 diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association
TA Pearson et al.
CIRCULATION (2003)
Mortality and causes of death in the WHO multinational study of vascular disease in diabetes
NJ Morrish et al.
DIABETOLOGIA (2001)
Share Paper
